Neuronetics (STIM) Retained Earnings (2017 - 2026)
Neuronetics (STIM) reported Retained Earnings of -$469.6 million for Q1 2026, down 8.57% year-over-year from -$513.6 million in Q1 2025, and down 2.35% quarter-over-quarter from -$458.8 million in Q4 2025.
Neuronetics (STIM) Retained Earnings (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Retained Earnings data on file, last reported at -$469.6 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$469.6 million, down 8.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$469.6 million (down 8.57% YoY), and the FY2025 annual result was -$458.8 million, down 9.29% from the prior year.
- Retained Earnings fell to -$469.6 million in Q1 2026 per STIM's latest filing, from -$458.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$319.6 million in Q1 2022 and troughed at -$469.6 million in Q1 2026.
- A 5-year average of -$391.6 million and a median of -$384.0 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings dropped 12.66% in 2022, then decreased 7.73% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$345.9 million in 2022, then retreated by 8.73% to -$376.1 million in 2023, then retreated by 11.62% to -$419.8 million in 2024, then decreased by 9.29% to -$458.8 million in 2025, then slipped by 2.35% to -$469.6 million in 2026.
- Business Quant data shows STIM's Retained Earnings at -$469.6 million in Q1 2026, -$458.8 million in Q4 2025, and -$451.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | -469.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -469.58 Mn |
| Dec 31, 2025 | -458.79 Mn |
| Sep 30, 2025 | -451.60 Mn |
| Jun 30, 2025 | -442.58 Mn |
| Mar 31, 2025 | -432.50 Mn |
| Dec 31, 2024 | -419.79 Mn |
| Sep 30, 2024 | -407.10 Mn |
| Jun 30, 2024 | -393.80 Mn |
| Mar 31, 2024 | -383.95 Mn |
| Dec 31, 2023 | -376.08 Mn |
| Sep 30, 2023 | -370.70 Mn |
| Jun 30, 2023 | -361.30 Mn |
| Mar 31, 2023 | -356.40 Mn |
| Dec 31, 2022 | -345.89 Mn |
| Sep 30, 2022 | -337.60 Mn |
| Jun 30, 2022 | -329.99 Mn |
| Mar 31, 2022 | -319.57 Mn |
| Dec 31, 2021 | -308.73 Mn |
| Sep 30, 2021 | -301.10 Mn |
| Jun 30, 2021 | -292.90 Mn |